Author: Liguori, Sara; Moretti, Antimo; Paoletta, Marco; Gimigliano, Francesca; Iolascon, Giovanni
Title: Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities Cord-id: qscclqqi Document date: 2021_2_19
ID: qscclqqi
Snippet: The outbreak of COVID-19 caused by SARS-CoV-2 has spread worldwide with a huge impact on the healthcare system. Compared to the previous coronaviruses-related pandemics, COVID-19 is more transmissible with potential systemic involvement and peculiar neurological manifestations, such as Guillan-Barrè syndrome up to critical illness myopathy, occurring in the intensive care setting. In this clinical scenario, people living with a neuromuscular disease (NMD) represent a vulnerable category with a
Document: The outbreak of COVID-19 caused by SARS-CoV-2 has spread worldwide with a huge impact on the healthcare system. Compared to the previous coronaviruses-related pandemics, COVID-19 is more transmissible with potential systemic involvement and peculiar neurological manifestations, such as Guillan-Barrè syndrome up to critical illness myopathy, occurring in the intensive care setting. In this clinical scenario, people living with a neuromuscular disease (NMD) represent a vulnerable category with a high risk of a severe course of COVID-19. Moreover, in the NMD population, the management of respiratory and muscular impairments after SARS-CoV-2 infection might be troubling in terms of both pharmacological and rehabilitative approaches. To date, rehabilitation is still an unmet need in this population with several implications on NMD progression with and without SARS-CoV-2 infection. In particular, rehabilitation intervention for patients with NMD after COVID-19 are lacking. Therefore, in the current paper, we analyze the critical issues of COVID-19 on NMDs patients and propose a home-based rehabilitation program targeted for this population after mild to moderate SARS-CoV-2 infection.
Search related documents:
Co phrase search for related documents- action mechanism and adaptive immune response: 1, 2, 3
- action mechanism and adjunctive therapy: 1, 2
- action mechanism and administration route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- action mechanism and low intensity: 1, 2
- action mechanism and lung function: 1, 2, 3, 4, 5, 6, 7
- active cycle and acute patient: 1
- acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and adequate ventilatory support: 1
- acute ards respiratory distress syndrome and adjunctive therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and administration route: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and adrenal insufficiency: 1, 2, 3
- acute ards respiratory distress syndrome and low intensity: 1
- acute ards respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung function improve: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lung recruitment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute patient and adjunctive therapy: 1
- acute patient and administration route: 1
- acute patient and adrenal insufficiency: 1
- acute patient and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date